2 months BIIB Secures FDA Nod for Monthly Maintenance Dosing of Alzheimer’s Drug Zacks

The FDA’s approval is based on simulation data from multiple studies showing that maintenance dosing with Biogen???s Leqembi every four weeks prolongs biomarker benefits.

Biogen (BIIB)

2 months BIIB Secures FDA Nod for Monthly Maintenance Dosing of Alzheimer’s Drug Zacks

3 days Biogen: Balancing Risks And Opportunities Seeking Alpha

2 weeks Biogen Inc. (BIIB) Stifel 2025 Virtual CNS Forum Conference (Transcript) Seeking Alpha

2 weeks Why Is Biogen (BIIB) Up 1.1% Since Last Earnings Report? Zacks

2 weeks Can BIIB’s New Drugs Revive Growth as Multiple Sclerosis Sales Fall? Zacks

3 weeks BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant Zacks

3 weeks Biogen Inc. (BIIB) Management presents at Leerink Global Healthcare Conference 2025 (Transcript) Seeking Alpha

3 weeks The Nasdaq is Cratering But REGN, BIIB and CSGP Are Up Big Today 24/7 Wall St.

4 weeks Biogen Inc. (BIIB) CEO Chris Viehbacher presents at TD Cowen 45th Annual Health Care Conference (Transcript) Seeking Alpha

1 month Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy MarketWatch

1 month Biogen Q4 Earnings Review: Why I’m Calling Time On This ‘Powder Puff’ Pharma Seeking Alpha

1 month Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance Zacks

2 months Biogen’s Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints Zacks

2 months Biogen Stock Falls After Company Gives Weaker-Than-Expected Financial Outlook Yahoo Finance

2 months Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma Yahoo Finance

2 months Biogen (BIIB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks

2 months Biogen Inc. 2024 Q4 – Results – Earnings Call Presentation Seeking Alpha

2 months Drugmaker Biogen forecasts 2025 profit below expectations Yahoo Finance

2 months Biogen Hammered As Lackluster Guidance Drags On Fourth-Quarter Beat Investor's Business Daily

2 months Bernstein starts Biogen at ‘market-perform,’ notes near term uncertainty Investing.com

2 months Biogen Gears Up to Report Q4 Earnings: What’s in the Cards? Zacks

2 months Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth Zacks

2 months Biogen Stock Down on Regulatory Update in the EU for Alzheimer’s Drug Zacks

2 months The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics Zacks

2 months Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report? Zacks

2 months Biotech Stock Roundup: SAGE Up on Declining BIIB’s Offer, CYTK, AKRO Up on Updates Zacks

The Stock Market News